JPMorgan Adjusts Cellebrite DI Price Target to $17 From $15, Maintains Overweight Rating

MT NewswiresAug 16 11:45 ET · Ratings

Cellebrite DI Is Maintained at Overweight by JP Morgan

Dow JonesAug 16 11:45 ET

Express News | Cellebrite DI Shares Are Trading Higher After Multiple Firms Raised Their Respective Price Targets on the Stock

BenzingaAug 16 10:25 ET

H&R Block Posts Upbeat Earnings, Joins Alibaba Group, CI&T And Other Big Stocks Moving Higher On Friday

BenzingaAug 16 10:15 ET

Earnings Call: Cellebrite Reports Robust Q2 Growth With ARR up 26%

InvestingAug 16 09:08 ET

Express News | Craig-Hallum Maintains Buy on Cellebrite DI, Raises Price Target to $20

BenzingaAug 16 09:08 ET